| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |